Adverum Biotechnologies Stock Analysis

Adverum Stock Analysis Notes

About 13.0% of the company shares are held by company insiders. The book value of Adverum Biotechnologies was presently reported as 1.26. The company recorded a loss per share of 7.22. Adverum Biotechnologies had not issued any dividends in recent years. The entity had 1:10 split on the 21st of March 2024. Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California. Adverum Biotechnlgs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 188 people. For more info on Adverum Biotechnologies please contact Laurent Fischer at 650 656 9323 or go to https://adverum.com.

Adverum Biotechnologies Investment Alerts

Adverum Biotechnologies Upcoming and Recent Events

Adverum Largest EPS Surprises

View All Earnings Estimates

Adverum Biotechnologies Environmental, Social, and Governance (ESG) Scores

Adverum Stock Institutional Investors

Note, although Adverum Biotechnologies' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Adverum Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 55.78 M.

Adverum Profitablity

Management Efficiency

Adverum Biotechnologies has return on total asset (ROA) of (0.4876) % which means that it has lost $0.4876 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4451) %, meaning that it created substantial loss on money invested by shareholders. Adverum Biotechnologies' management efficiency ratios could be used to measure how well Adverum Biotechnologies manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of July 2025, Return On Tangible Assets is likely to drop to -0.76. In addition to that, Return On Capital Employed is likely to grow to -0.84. At this time, Adverum Biotechnologies' Intangible Assets are very stable compared to the past year.

Technical Drivers

As of the 25th of July, Adverum Biotechnologies shows the Downside Deviation of 5.72, mean deviation of 4.7, and Risk Adjusted Performance of 0.0294. Adverum Biotechnologies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Adverum Biotechnologies variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Adverum Biotechnologies is priced correctly, providing market reflects its regular price of 2.7 per share. Please also double-check Adverum Biotechnologies total risk alpha, which is currently at (1.59) to validate the company can sustain itself at a future point.

Adverum Biotechnologies Price Movement Analysis

Adverum Biotechnologies Insider Trading Activities

Adverum Biotechnologies Outstanding Bonds

Adverum Biotechnologies Predictive Daily Indicators

Adverum Biotechnologies Forecast Models

Adverum Biotechnologies' time-series forecasting models are one of many Adverum Biotechnologies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Adverum Biotechnologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Adverum Biotechnologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Adverum shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Adverum Biotechnologies. By using and applying Adverum Stock analysis, traders can create a robust methodology for identifying Adverum entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Adverum analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Adverum analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Adverum Biotechnologies stock analysis indicators help investors evaluate how Adverum Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Adverum Biotechnologies shares will generate the highest return on investment. By understating and applying Adverum Biotechnologies stock analysis, traders can identify Adverum Biotechnologies position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.